PACE Talks

06/11/2011

Prof. John Betteridge and prof. Chris Packard talk about HDL as the next target in terms of a global approach to lipid and lipoprotein management. The epidemiology is strong that low HDL is a very important risk factor.

HDL as the next target in lipid management
News - Nov. 6, 2011

Prof. John Betteridge and prof. Chris Packard talk about HDL as the next target in terms of a global approach to lipid and lipoprotein management.

Register

We're glad to see you're enjoying PACE-CME…
but how about a more personalized experience?

Register for free